ReechPharma
Private Company
Funding information not available
Overview
ReechPharma operates as a service-oriented contract development organization (CDO) specializing in advanced drug formulation and delivery systems. It leverages deep technical expertise to help clients overcome development hurdles, accelerate timelines, and enhance the clinical success potential of their drug candidates. The company has established a strong reputation in the San Francisco Bay Area and broader biotech community, as evidenced by numerous client testimonials praising its collaborative approach and problem-solving capabilities. Its business model is built on serving as an extended development arm for both emerging biotechs and established pharmaceutical companies.
Technology Platform
Applied expertise in physicochemical and biopharmaceutical principles for customized formulation design across multiple drug delivery routes (oral, transdermal, ocular, etc.), with a focus on solubility/permeability enhancement, modified-release systems, and IP enrichment.
Opportunities
Risk Factors
Competitive Landscape
ReechPharma competes in a crowded market including large, full-service global CDMOs (e.g., Lonza, Catalent) and numerous smaller, specialized formulation development shops. Its differentiation lies in its deep scientific collaboration, focus on early-stage problem-solving, and strong reputation within the California biotech network, rather than scale or manufacturing capacity.